Trial intelligence / Profile preview

Acute Mechanical Response to Anti-arrhythmic Drug Therapy

NCT02575534Withdrawn

Start
Oct 2015
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of procainamide in cardiac arrhythmia. Primary endpoints: Change in QRS duration, Changes in left ventricular volumes and 2 more. Planned start Oct 2015; status: withdrawn.

02

Drugs

procainamide
03

Conditions

cardiac arrhythmia

Beyond the preview

Go deeper on NCT02575534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02575534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call